NewsBenzingaEntrada Therapeutics Q3 BPA de $(0,94) supera la estimación de $(1,01), ventas de $905.000K quedan por debajo de la estimación de $5.871M Entrada Therapeutics Q3 BPA de $(0,94) supera la estimación de $(1,01), ventas de $905.000K quedan por debajo de la estimación de $5.871M Benzinga 2026.11.05 13:02 (GMT+0) Open on Benzinga Other news Israeli Shipping Giant ZIM Cashes In on Surging Freight Rates, Raises Outlook UBS Maintains Buy on Home Depot, Lowers Price Target to $417 Disney Posts Upbeat Q4, Analysts Raise Price Target Citing Theme Park Resilience StoneX Maintains Buy on Bitdeer Techs, Lowers Price Target to $15 Merck Pulls Plug On Acquired Drug after Safety Review UBS Maintains Neutral on Granite Point Mortgage Tr, Lowers Price Target to $3